04/23/2024 7:21 PM | Arcus Biosciences (Filer)
| Form ARS | |
04/23/2024 3:08 PM | Arcus Biosciences (Filer)
| Form DEF 14A | |
04/23/2024 3:10 PM | Arcus Biosciences (Filer)
| Form DEFA14A | |
03/29/2024 3:20 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:19 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:30 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 6:55 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/28/2024 6:55 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:49 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4/A | |
02/21/2024 3:53 PM | Arcus Biosciences (Filer)
| Form S-3ASR | |
02/21/2024 3:16 PM | Arcus Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 7:35 AM | Arcus Biosciences (Subject) FMR LLC (Filed by)
| Form SC 13G | |
02/07/2024 5:58 PM | Arcus Biosciences (Issuer) Mercier Johanna (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/31/2024 3:58 PM | Arcus Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D/A | |
01/31/2024 4:00 PM | Arcus Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 7:17 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 6:38 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 6:33 AM | Arcus Biosciences (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 10:52 AM | Arcus Biosciences (Subject)
| Form SC 13G/A | |
01/04/2024 4:22 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:23 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:44 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:47 PM | Arcus Biosciences (Subject) Goeltz II Robert C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 4:17 PM | Arcus Biosciences (Subject) Jaen Juan C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:20 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:06 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:28 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 3:35 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Crypto 9-5 Escape Plan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
09/22/2023 3:16 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 3:46 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:47 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 3:53 PM | Arcus Biosciences (Subject) Nuyten Dimitry SA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023 3:49 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023 7:08 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 7:13 AM | Arcus Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023 3:15 PM | Arcus Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:15 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 8:38 AM | Arcus Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D/A | |
06/30/2023 2:12 PM | Arcus Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 7:25 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 3:36 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:07 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 7:16 PM | Arcus Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:16 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:17 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:01 PM | Arcus Biosciences (Issuer) FALBERG KATHRYN E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:03 PM | Arcus Biosciences (Issuer) KANEKO YASUNORI (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:05 PM | Arcus Biosciences (Issuer) Machado Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:06 PM | Arcus Biosciences (Issuer) Ribas Antoni (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:08 PM | Arcus Biosciences (Issuer) Lacey David L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:09 PM | Arcus Biosciences (Issuer) PERLMAN ANDREW J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:11 PM | Arcus Biosciences (Issuer) Lambert Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:12 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:14 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:19 PM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 3:12 PM | Arcus Biosciences (Subject) ROSEN TERRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 3:15 PM | Arcus Biosciences (Subject) Jaen Juan C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 3:18 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 1:17 PM | Arcus Biosciences (Subject) Goeltz II Robert C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 7:25 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 7:34 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |